One other striking finding demonstrated that deletion of SREBP1c in the liver of ob/ob mice resulted in a 50% reduction of hepatic triglycerides, portraying the unique role of SREBP1c in hepatic steatosis exhibited by insulin resistance [67]. Here, SREBF1 is linked to steatosis.